Options
Clinical update on fractionated radioimmunotherapy in patients with NHL using humanized 90Y labeled anti-CD22 epratuzumab
ISSN
0923-7534
Date Issued
2005
Author(s)
Chatal, J.
Harousseau, J.
Griesinger, Frank
Pfreundschuh, Michael
Kirsch, Carl-Martin
Naumann, R.
Kropp, Joachim
Morschhauser, Franck
Huglo, Damien